Stem Cell Manufacturing Market grew USD 18.0 Billion by 2026, at a CAGR of 9.4% – Exclusive Report by MarketsandMarkets™

November 04 18:33 2022
Stem Cell Manufacturing Market grew USD 18.0 Billion by 2026, at a CAGR of 9.4% - Exclusive Report by MarketsandMarkets™
The prominent players operating in the stem cell manufacturing market are Thermo Fisher Scientific (US), Merck Milliopore (Germany), Lonza Group AG (Switzerland), Danaher Corporation (US) and Sartorius AG (Germany).
In January 2021, Thermo Fisher Scientific acquired Henogen S.A., Novasep’s viral vector manufacturing business, to strengthen its capabilities for cell and gene vaccines and therapies globally.

According to the new market research report Stem Cell Manufacturing Market by Product (Consumables, Instrument, HSCs, MSCs, iPSCs, ESCs), Application (Research, Clinical {Autologous, Allogenic}, Cell & Tissue Banking), End User (Pharma & Biotech, Hospitals, Tissue Bank) – Global Forecast to 2026″, published by MarketsandMarkets™, the global market is projected to reach USD 18.0 billion by 2026 from USD 11.5 billion in 2021, at a CAGR of 9.4% during the forecast period.

Browse in-depth TOC on “Stem Cell Manufacturing Market”  

304 – Tables

43 – Figures

296 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=70743403

The Growing venture capital funding in stem cell-based research, rising awareness about the therapeutic potency of stem cell products, and supportive regulatory framework across developing countries are the key factors supporting the growth of the market. However, significant operational costs associated with stem cell manufacturing and banking are expected to hinder the overall growth rate.

Consumables accounted for the largest share of stem cell manufacturing market

The Stem cell manufacturing market by product is categorized into Consumables, Instruments, Stem Cell Lines. The consumables segment dominated the market in 2020. The large share of this segment can be attributed to frequent purchase of consumables, rising stem cell research and increasing demand for stem cell therapies. Stem cell lines segment is expected to register the highest CAGR during the forecast period due to growing demand for functionally potent stem cell lines in research, and the development of innovative stem cell culture & preservation techniques.

Research applications accounted for the largest share of stem cell manufacturing market

On the basis of application, the market is categorized into research applications, clinical application and cell & tissue banking applications. The research applications segment is further categorized into life science research and drug discovery & development. The research application segment dominated the market in 2020. The growth of this segment is attributed to the rising focus on stem cell cytology & pathophysiology research, and growing public-private funding to support stem cell product development and commercialization.

The Pharma & Biotech companies is the fastest-growing end-user segment of the stem cell manufacturing market

Based on end-users, the market is segmented into pharmaceutical & biotechnology companies, academic institutes, research laboratories & contract research organizations, hospitals & surgical centers, cell banks & tissue banks and other end users. The pharmaceutical & biotechnology companies segment held the largest market share in 2020, owing to growing emphasis on strategic initiatives (such as acquisitions, partnerships, and collaborations) by pharma and biotech companies to expand their capabilities in stem cell research.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=70743403

North America accounted for the largest share of the stem cell manufacturing market

The stem cell manufacturing market is segmented into North America, Europe, the Asia Pacific (APAC), Latin America (LATAM), and the Middle East and Africa (MEA). In 2020, North America accounted for the largest share of the global market, followed by Europe. This market is primarily driven by the extensive ongoing stem cell research activities, and the availability of public-private funding and grants to support the clinical evaluation of stem cells for various applications.

The prominent players operating in the stem cell manufacturing market are Thermo Fisher Scientific (US), Merck Milliopore (Germany), Lonza Group AG (Switzerland), Danaher Corporation (US) and Sartorius AG (Germany).

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=70743403

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/stem-cell-manufacturing-market-70743403.html?